Strategic Deployment Manager, Life Science

New York, New York, United States

Apply with AI Apply

$100,000 – $160,000Compensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Life Science, Pharmaceuticals, Biotechnology, Chemicals, Enterprise SoftwareIndustries

Requirements

Candidates should possess a Bachelor’s degree in a life science, with a Master’s or Ph.D. being preferred, and at least three years of experience in a life sciences field related to drug discovery, including experience with computational chemistry or cheminformatics in a research setting.

Responsibilities

The Strategic Deployment Manager will manage LiveDesign implementation projects from initial discussions through deployment, training, and growth, ensuring long-term customer success by utilizing the Schrödinger Platform. They will collaborate internally with various teams to enable account growth and usage, and will actively help drive the product roadmap and development by representing real-world customer needs alongside product management and engineering.

Skills

Pharmaceutical enterprise software

Chemical enterprise software

Project management

Customer success

Product roadmap

Deployment

Training

Communication

Organization

Schrödinger

Computational platform for biopharmaceutical research

About Schrödinger

Schrödinger provides a computational platform that aids in the research efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. Their platform offers advanced computational tools that help in drug discovery and development across various therapeutic areas. Schrödinger's products work by using sophisticated algorithms and simulations to predict how different compounds will interact, which can significantly speed up the research process. Unlike many competitors, Schrödinger not only licenses its software but also engages in collaborative research and drug discovery programs, allowing for a more integrated approach to scientific research. The company's goal is to enhance scientific research and development through its platform, ultimately leading to the discovery of new drugs and therapies.

New York City, New YorkHeadquarters

1990Year Founded

$362.7MTotal Funding

IPOCompany Stage

Government & Public Sector, Enterprise Software, BiotechnologyIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Paid Vacation

Parental Leave

Risks

Recursion and Exscientia merger creates strong AI-driven drug discovery competitor.

Avicenna's independent expansion could lead to competitive tensions with Schrödinger.

High R&D costs may strain resources despite Gates Foundation's $10M grant.

Differentiation

Schrödinger's platform supports diverse clients, including biopharma, academia, and government labs.

The company excels in rapid drug discovery, exemplified by SGR-1505's swift development.

Schrödinger's collaboration with Avicenna enhances medicinal chemistry through machine learning.

Upsides

$19.5M Gates Foundation grant boosts platform for neglected diseases, expanding market reach.

Predictive toxicology tools initiative could lead to safer, efficient drug development.

SGR-1505 discovery showcases ability to reduce drug discovery timelines significantly.

Land your dream remote job 3x faster with AI

Try Jobo Free